Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?

Autor: van Heuckelum M; Sint Maartenskliniek, Nijmegen, The Netherlands., Hebing RCF; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands., Vandeberg L; Centre for Language Studies, Radboud University, Nijmegen, The Netherlands, and Amsterdam School of Communication Research, University of Amsterdam, Amsterdam, The Netherlands., Linn AJ; Amsterdam School of Communication Research, University of Amsterdam, Amsterdam, The Netherlands., Flendrie M; Sint Maartenskliniek, Nijmegen, The Netherlands., Nurmohamed MT; Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, The Netherlands., van Dulmen S; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands, and University of South-Eastern Norway, Drammen, Norway., van den Ende CHM; Sint Maartenskliniek and Radboud University Medical Center, Nijmegen, The Netherlands., van den Bemt BJF; Sint Maartenskliniek and Radboud University Medical Center, Nijmegen, The Netherlands, and Maastricht University Medical Centre, Maastricht, The Netherlands.
Jazyk: angličtina
Zdroj: Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Mar; Vol. 73 (3), pp. 364-373.
DOI: 10.1002/acr.24186
Abstrakt: Objective: It is generally unknown how the attitudes and beliefs of health care professionals (HCPs) might affect the attitudes, beliefs, and medication-taking behavior of patients with rheumatoid arthritis (RA). This study aims 1) to examine the attitudes, health-related associations (both implicit and explicit), and beliefs of HCPs about conventional disease-modifying antirheumatic drugs, and 2) to assess whether these attitudes, health-related associations, and beliefs of HCPs are associated with those of their patients, with their patients' medication-taking behavior, and disease activity.
Methods: HCPs were recruited from 2 centers that specialized in rheumatology across The Netherlands, and patient recruitment followed. In this observational study, implicit outcomes were measured with single-category implicit association tests, whereas explicit outcomes were measured with a bipolar evaluative adjective scale and the Beliefs About Medicines Questionnaire-Specific. Spearman's rank correlations were used to describe correlations between implicit and explicit measures of the attitudes of HCPs. Multilevel, mixed-effects linear models were used to examine the association of HCP-related characteristics, including the implicit and explicit outcomes of HCPs, with those of their patients, their medication-taking behaviors, and disease activity.
Results: Of the 1,659 initially invited patients, 254 patients with RA (mean age 62.8 years, mean disease duration 11.8 years, and 68.1% of the patients were female) who were treated by 26 different HCPs agreed to participate in this study. The characteristics, attitudes, health-related associations, and beliefs about medicines of HCPs were not significantly associated with those of their patients, nor with their medication-taking behaviors or disease activity scores.
Conclusion: This study demonstrated that the attitudes, health-related associations (as measured both implicitly and explicitly), and beliefs of HCPs were not significantly associated with the attitudes, beliefs, medication-taking behavior, and disease activity of patients with RA.
(© 2020, American College of Rheumatology.)
Databáze: MEDLINE
Externí odkaz: